Behavioral Medicine – Substance Use Disorders Practice Test

Cannabis use disorder currently has no FDA-approved medication specifically for treatment. The mainstay of management is psychosocial therapies, such as cognitive-behavioral therapy, motivational enhancement therapy, and contingency management, which help individuals reduce use, cope with triggers, and maintain abstinence or reduced use over time. When cannabis is stopped, withdrawal symptoms can occur—irritability, sleep problems, decreased appetite, restlessness, anxiety, and cravings—typically peaking within the first few days and resolving over one to two weeks. Because there isn’t a proven pharmacologic cure, withdrawal is managed with supportive care aimed at easing symptoms and maintaining comfort, sleep, and hydration, along with addressing any coexisting mental health or substance use issues.

Some medications have been studied off-label to help with withdrawal symptoms or cravings (for example, certain anticonvulsants or glutamate-modulating agents), but none are approved specifically for cannabis use disorder. The key point is that the best-supported approach remains psychosocial treatment, with pharmacologic options considered only off-label in specific situations.